Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · December 04, 2024

Effect of Discontinuing Long-Term Spironolactone Treatment on Kidney Function Markers Among Individuals With Type 2 Diabetes and a High Risk of Kidney Disease

Diabetes, Obesity & Metabolism

 

Additional Info

Disclosure statements are available on the authors' profiles:

Diabetes, Obesity & Metabolism
Effect of spironolactone wash-out on albuminuria after long-term treatment in individuals with type 2 diabetes and high risk of kidney disease-An observational follow-up of the PRIORITY study
Diabetes Obes Metab 2024 Oct 28;[EPub Ahead of Print], V Wasehuus, V Rotbain Curovic, N Tofte, M Lindhardt, G Currie, C Delles, M Frimodt-Møller, H Mischak, H von der Leyen, TW Hansen, T Kümler, F Persson, P Rossing

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading